viewTexas Instruments

Texas Instruments' CEO Brian Crutcher resigns for violating the company's code of conduct

Chairman Rich Templeton will reassume the roles of president and CEO in the wake of Crutcher's departure

Tristan Gerra, a senior analyst with Baird Equity Research, is keeping a Neutral rating and a US$115 on TI's shares

CEO Brian Crutcher has resigned from the chip maker Texas Instruments Inc (NASDAQ:TXN) for violating the company’s code of conduct.

Rich Templeton, Texas Instrument’s chairman, will reassume the roles of president and chief executive in the wake of Crutcher’s departure. The company said his appointment is “not temporary and the board is not searching for a replacement.”

The only detailed comments made about Crutcher’s departure was that his alleged violations of the company’s code of conduct related to “personal behavior that is not consistent with our ethics and core values”.

Crutcher had only been in the job for less than two months as he had been named president and CEO of Texas Instruments at the start of June, when he replaced Templeton.

Separately, TI also posted second-quarter revenue of US$4.02bn, which was over a 9% jump from the same-period last year. Its earnings per share swung to US$1.40, which included a tax benefit of US$0.3 per share.

Wall Street analysts remain optimistic about Texas Instruments

Despite the management shake-up, Tristan Gerra, a senior research analyst with Baird Equity Research, remains somewhat bullish on the company.

He argues that 2018 is “shaping up as another year of semiconductor revenue growing double digits, leading us to remain positive on the group for this year.”

The risks for the company which Gerra outlines include the possibility of market share loss in key markets due to competition as well as pricing pressures.

“Lower-end analog integrated circuits and discrete products are commodity semiconductors and can be subject to intense pricing pressures,” he wrote in a note to investors.

“Pricing pressures represent a risk to revenue and gross margin,” he added.

Gerra is keeping a Neutral rating and a US$115 price target on the stock.

Read: Chipmaker Texas Instruments hits bum note as revenue growth slows in fourth quarter

Oppenheimer's Rick Schafer also sees no "fundamental impact" from the management transition and is keeping his Outperform rating and a US$130 price target on the stock.

"Our thesis is unchanged," he wrote in a note to investors. "We view Texas Instruments as the top diversified steward of capital ... with an established record of consistent execution."

Dallas-based Texas Instruments is one of the biggest chipmakers, with a market cap of over US$113bn.

Contact Ellen Kelleher: [email protected]

Quick facts: Texas Instruments

Price: 124.77 USD

Market: NYSE
Market Cap: $114.51 billion

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



Rakuten Medical receives conditional approval in Japan for head and neck...

Rakuten Medical, Inc VP of Global Regulatory Peggy Berry tells Proactive the California-based biotechnology group has received conditional early approval from the Japanese Ministry of Health, Labor, and Welfare (MHLW). Berry says the privately-held group's lead drug ASP-1929, which aims to...

15 hours, 7 minutes ago

2 min read